Upgrade to SI Premium - Free Trial

Cytokinetics (CYTK) PT Raised to $75 at JPMorgan on Favorable Near-Term Outlook

March 17, 2026 7:09 AM
(Updated - March 17, 2026 7:10 AM EDT)

JPMorgan analyst Tessa Romero raised the price target on Cytokinetics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change